Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044972644> ?p ?o ?g. }
- W2044972644 endingPage "341" @default.
- W2044972644 startingPage "327" @default.
- W2044972644 abstract "Competitive N-methyl-d-aspartate receptor (NMDAR) antagonists bind to the GluN2 subunit, of which there are four types (GluN2A-D). We report that some N(1)-substituted derivatives of cis-piperazine-2,3-dicarboxylic acid display improved relative affinity for GluN2C and GluN2D versus GluN2A and GluN2B. These derivatives also display subtype selectivity among the more distantly related kainate receptor family. Compounds 18i and (-)-4 were the most potent kainate receptor antagonists, and 18i was selective for GluK1 versus GluK2, GluK3 and AMPA receptors. Modeling studies revealed structural features required for activity at GluK1 subunits and suggested that S674 was vital for antagonist activity. Consistent with this hypothesis, replacing the equivalent residue in GluK3 (alanine) with a serine imparts 18i antagonist activity. Antagonists with dual GluN2D and GluK1 antagonist activity may have beneficial effects in various neurological disorders. Consistent with this idea, antagonist 18i (30 mg/kg ip) showed antinociceptive effects in an animal model of mild nerve injury." @default.
- W2044972644 created "2016-06-24" @default.
- W2044972644 creator A5002091267 @default.
- W2044972644 creator A5005931263 @default.
- W2044972644 creator A5011841451 @default.
- W2044972644 creator A5014746560 @default.
- W2044972644 creator A5017555495 @default.
- W2044972644 creator A5022921281 @default.
- W2044972644 creator A5029957711 @default.
- W2044972644 creator A5036531183 @default.
- W2044972644 creator A5039078540 @default.
- W2044972644 creator A5039824894 @default.
- W2044972644 creator A5042844182 @default.
- W2044972644 creator A5050274341 @default.
- W2044972644 creator A5054968546 @default.
- W2044972644 creator A5072895674 @default.
- W2044972644 creator A5074935915 @default.
- W2044972644 creator A5083626701 @default.
- W2044972644 creator A5084414413 @default.
- W2044972644 creator A5090967798 @default.
- W2044972644 date "2011-12-14" @default.
- W2044972644 modified "2023-10-05" @default.
- W2044972644 title "Piperazine-2,3-dicarboxylic Acid Derivatives as Dual Antagonists of NMDA and GluK1-Containing Kainate Receptors" @default.
- W2044972644 cites W1500903443 @default.
- W2044972644 cites W1584538406 @default.
- W2044972644 cites W1637705010 @default.
- W2044972644 cites W1970456058 @default.
- W2044972644 cites W1971235606 @default.
- W2044972644 cites W1971335215 @default.
- W2044972644 cites W1971957467 @default.
- W2044972644 cites W1973732479 @default.
- W2044972644 cites W1982028592 @default.
- W2044972644 cites W1982082399 @default.
- W2044972644 cites W1986502812 @default.
- W2044972644 cites W1994403933 @default.
- W2044972644 cites W1995279806 @default.
- W2044972644 cites W2002269793 @default.
- W2044972644 cites W2008188786 @default.
- W2044972644 cites W2014007136 @default.
- W2044972644 cites W2014557178 @default.
- W2044972644 cites W2017439663 @default.
- W2044972644 cites W2017932377 @default.
- W2044972644 cites W2021342314 @default.
- W2044972644 cites W2025428848 @default.
- W2044972644 cites W2027743644 @default.
- W2044972644 cites W2029181178 @default.
- W2044972644 cites W2037852973 @default.
- W2044972644 cites W2038471077 @default.
- W2044972644 cites W2043217144 @default.
- W2044972644 cites W2048346495 @default.
- W2044972644 cites W2054551300 @default.
- W2044972644 cites W2063847663 @default.
- W2044972644 cites W2065351751 @default.
- W2044972644 cites W2069810014 @default.
- W2044972644 cites W2074220016 @default.
- W2044972644 cites W2074631079 @default.
- W2044972644 cites W2074907255 @default.
- W2044972644 cites W2076339408 @default.
- W2044972644 cites W2078662595 @default.
- W2044972644 cites W2080849407 @default.
- W2044972644 cites W2090148618 @default.
- W2044972644 cites W2090590009 @default.
- W2044972644 cites W2095358033 @default.
- W2044972644 cites W2097693778 @default.
- W2044972644 cites W2103799907 @default.
- W2044972644 cites W2107339318 @default.
- W2044972644 cites W2108125732 @default.
- W2044972644 cites W2112871431 @default.
- W2044972644 cites W2122532139 @default.
- W2044972644 cites W2130314959 @default.
- W2044972644 cites W2131765996 @default.
- W2044972644 cites W2132492832 @default.
- W2044972644 cites W2133048825 @default.
- W2044972644 cites W2142479105 @default.
- W2044972644 cites W2172060122 @default.
- W2044972644 cites W2328184911 @default.
- W2044972644 cites W2335664078 @default.
- W2044972644 doi "https://doi.org/10.1021/jm201230z" @default.
- W2044972644 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3269097" @default.
- W2044972644 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22111545" @default.
- W2044972644 hasPublicationYear "2011" @default.
- W2044972644 type Work @default.
- W2044972644 sameAs 2044972644 @default.
- W2044972644 citedByCount "17" @default.
- W2044972644 countsByYear W20449726442012 @default.
- W2044972644 countsByYear W20449726442014 @default.
- W2044972644 countsByYear W20449726442015 @default.
- W2044972644 countsByYear W20449726442016 @default.
- W2044972644 countsByYear W20449726442017 @default.
- W2044972644 countsByYear W20449726442018 @default.
- W2044972644 countsByYear W20449726442019 @default.
- W2044972644 countsByYear W20449726442020 @default.
- W2044972644 countsByYear W20449726442021 @default.
- W2044972644 countsByYear W20449726442022 @default.
- W2044972644 crossrefType "journal-article" @default.
- W2044972644 hasAuthorship W2044972644A5002091267 @default.
- W2044972644 hasAuthorship W2044972644A5005931263 @default.
- W2044972644 hasAuthorship W2044972644A5011841451 @default.